CRISPR Based Technologies and Bio-products


Genome piece of writing and the utilization of CRISPR based technologies are expected to revolutionize the assembly of succeeding generation of bio product. DCB12 will consider the foremost recent developments among the use of CRISPR/Cas9 and different CRISPR based technologies in relevance the event and production of biopharmaceuticals, biochemical, agricultural crops and travel applications. The worldwide marketplace for genetic modification therapies should grow from $2.3 billion in 2018 to achieve $17.4 billion by 2023, growing at a compound annual rate of growth (CAGR) of 49.9% during the forecast period of 2018-2023.


    Related Conference of CRISPR Based Technologies and Bio-products

    June 16-17, 2025

    21st Global Summit on Stem Cell & Regenerative Medicine

    Frankfurt, Germany
    July 21-22, 2025

    18th World Congress on Stem Cell Research

    Barcelona, Spain
    September 25-26, 2025

    6th Annual summit on Cell Signaling and Cancer Therapy

    Montreal, Canada

    CRISPR Based Technologies and Bio-products Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in